He didn’t say AML was not on an approval pathway. He said the Sheba trial wasn’t. Because Bisantrene is being used in conbo compared to historical trials being single agent.
He didn’t say AML was not on an approval pathway. He said the...
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.050(3.03%) |
Mkt cap ! $289.6M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.70 | $1.63 | $181.9K | 109.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11946 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 27579 | 4 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |